DNA X, Inc. - Common Stock — Cash Flow (NASDAQ:SONM) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -10.56 M-38.48 M-12.36 M-4.05 M-8.49 M-23.53 M -17.39 M Cash from investing activities -11 K-46 K-8 000-36 K-214 K0 3.36 M Cash from financing activities 21.41 M27.61 M14.35 M272 K4.65 M19.49 M 13.11 M Free cash flow -10.56 M-38.48 M-12.36 M-4.05 M-8.49 M-23.53 M -17.39 M

News

Sonim Technologies rebrands as DNA X following asset sale to NEXA

Sonim stockholders approve sale of rugged device business to NEXA

Dow Gains Over 100 Points; US Jobless Claims Decline - Citius Pharmaceuticals (NASDAQ:CTXR), Multi Ways Holdings (AMEX:MWG)

Why Vision Marine Technologies Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - CEA Industries (NASDAQ:BNC), Aditxt (NASDAQ:ADTX)

Sonim Technologies to vote on $15 million asset sale to NEXA

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.71%

Upcoming Stock Splits This Week (October 27 to October 31) – Stay Invested - TipRanks.com

Sonim Technologies to implement 1-for-18 reverse stock split on October 27

Why Crown Holdings Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket - Aditxt (NASDAQ:ADTX), Adaptimmune Therapeutics (NASDAQ:ADAP)

Sonim launches ultra-rugged XP3plus 5G flip phone on AT&T

Sonim launches ultra-rugged XP Pro smartphone across Canada

Sonim Technologies grants special director awards and reports annual meeting vote results